PGEN
Precigen, Inc.
Biopharmaceutical company developing gene and cell therapies
CUSIP: 74017N105HealthcareUS1 holder
Total Value
$25.31M
Total Shares
17.45M
Net Share Change
+1.47M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Patient Capital Management
$25.31M17.45M shares
ADD+1.47M(+9.2%)